Literature DB >> 12801874

Classification of multiple cancer types by multicategory support vector machines using gene expression data.

Yoonkyung Lee1, Cheol-Koo Lee.   

Abstract

MOTIVATION: High-density DNA microarray measures the activities of several thousand genes simultaneously and the gene expression profiles have been used for the cancer classification recently. This new approach promises to give better therapeutic measurements to cancer patients by diagnosing cancer types with improved accuracy. The Support Vector Machine (SVM) is one of the classification methods successfully applied to the cancer diagnosis problems. However, its optimal extension to more than two classes was not obvious, which might impose limitations in its application to multiple tumor types. We briefly introduce the Multicategory SVM, which is a recently proposed extension of the binary SVM, and apply it to multiclass cancer diagnosis problems.
RESULTS: Its applicability is demonstrated on the leukemia data (Golub et al., 1999) and the small round blue cell tumors of childhood data (Khan et al., 2001). Comparable classification accuracy shown in the applications and its flexibility render the MSVM a viable alternative to other classification methods. SUPPLEMENTARY INFORMATION: http://www.stat.ohio-state.edu/~yklee/msvm.htm

Entities:  

Mesh:

Year:  2003        PMID: 12801874     DOI: 10.1093/bioinformatics/btg102

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  40 in total

1.  A hybrid BPSO-CGA approach for gene selection and classification of microarray data.

Authors:  Li-Yeh Chuang; Cheng-Huei Yang; Jung-Chike Li; Cheng-Hong Yang
Journal:  J Comput Biol       Date:  2011-01-06       Impact factor: 1.479

Review 2.  Metabolic engineering in the -omics era: elucidating and modulating regulatory networks.

Authors:  Goutham N Vemuri; Aristos A Aristidou
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

3.  A support vector machine approach to classify human cytochrome P450 3A4 inhibitors.

Authors:  Jan M Kriegl; Thomas Arnhold; Bernd Beck; Thomas Fox
Journal:  J Comput Aided Mol Des       Date:  2005-03       Impact factor: 3.686

4.  Kernel machine approach to testing the significance of multiple genetic markers for risk prediction.

Authors:  Tianxi Cai; Giulia Tonini; Xihong Lin
Journal:  Biometrics       Date:  2011-01-31       Impact factor: 2.571

5.  A simple and exact Laplacian clustering of complex networking phenomena: application to gene expression profiles.

Authors:  Choongrak Kim; Mookyung Cheon; Minho Kang; Iksoo Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

6.  Gene selection for multiclass prediction by weighted Fisher criterion.

Authors:  Jianhua Xuan; Yue Wang; Yibin Dong; Yuanjian Feng; Bin Wang; Javed Khan; Maria Bakay; Zuyi Wang; Lauren Pachman; Sara Winokur; Yi-Wen Chen; Robert Clarke; Eric Hoffman
Journal:  EURASIP J Bioinform Syst Biol       Date:  2007

7.  Classifying clinical notes with pain assessment using machine learning.

Authors:  Samah Jamal Fodeh; Dezon Finch; Lina Bouayad; Stephen L Luther; Han Ling; Robert D Kerns; Cynthia Brandt
Journal:  Med Biol Eng Comput       Date:  2017-12-26       Impact factor: 2.602

8.  Machine learning algorithms to classify spinal muscular atrophy subtypes.

Authors:  Tuhin Srivastava; Basil T Darras; Jim S Wu; Seward B Rutkove
Journal:  Neurology       Date:  2012-07-11       Impact factor: 9.910

9.  Gene expression based leukemia sub-classification using committee neural networks.

Authors:  Mihir S Sewak; Narender P Reddy; Zhong-Hui Duan
Journal:  Bioinform Biol Insights       Date:  2009-09-03

10.  Predictive response-relevant clustering of expression data provides insights into disease processes.

Authors:  Lisa E M Hopcroft; Martin W McBride; Keith J Harris; Amanda K Sampson; John D McClure; Delyth Graham; Graham Young; Tessa L Holyoake; Mark A Girolami; Anna F Dominiczak
Journal:  Nucleic Acids Res       Date:  2010-06-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.